Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 7/20 | 0.49 |
| ▸ | ELANE | P08246 | 1/20 | 0.45 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.44 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 2/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29425919 | 0.97 | PTPN1 (0.52) | PTPN1ELANEPTPN2PTPN11CYP3A4 | |
| 6'-O-P-Coumaroylgenipin Gentiobioside SCHEMBL29689589 | 0.92 | ELANE (0.53) | PTPN1ELANE | |
| SCHEMBL29426143 | 0.89 | PRKCA (0.52) | PTPN1ELANEPRKCACYP19A1 | |
| Tarenninoside E SCHEMBL29426088 | 0.83 | PTPN1 (0.46) | PTPN1ELANEPTPN2PTPN11PRKCA | |
| Tarenninoside D SCHEMBL29426111 | 0.78 | PRKCA (0.46) | PTPN1ELANEPRKCACYP19A1CA12 | |
| Geniposidic Acid SCHEMBL227010 | 0.78 | PTPN1 (0.70) | PTPN1PTPN2PTPN11 | |
| SCHEMBL29426041 | 0.77 | HSP90AA1 (0.46) | ELANEPRKCACYP19A1CYP3A4CA12 | |
| Genipin Gentiobioside SCHEMBL28007135 | 0.75 | PTPN1 (0.64) | PTPN1 | |
| SCHEMBL29425910 | 0.75 | PRKCA (0.49) | ELANEPRKCACYP19A1CYP3A4CA12 | |
| SCHEMBL31179879 | 0.73 | HSP90AA1 (0.55) | ELANEPRKCACYP3A4CA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702037-A1 | METHOD OF PRODUCING IRIDOIDS | Nicoventures Trading Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024224085-A1 | METHOD OF PRODUCING IRIDOIDS | Nicoventures Trading Limited (GB) | 2024-10-31 | — | — | WO | disclosed |
| EP-3592432-B2 | GARDENIA EXTRACT USED FOR COLORING KERATIN FIBERS | FABRE PIERRE DERMO COSMETIQUE (FR) | 2024-07-17 | — | — | EP | disclosed |
| CN-115728404-A | Lanqin oral liquid contrast extract and preparation method and application thereof | 扬子江药业集团有限公司 | 2023-03-03 | — | — | CN | disclosed |
| EP-3409766-B1 | AN ESTERASE THAT IS CAPABLE OF CONVERTING IRIDOIDS AND SECO-IRIDOIDS | N ZYME BIOTEC GMBH (DE) | 2022-03-09 | — | — | EP | disclosed |
| US-11266593-B2 | Gardenia extract for dyeing keratin fibres | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2022-03-08 | — | — | US | disclosed |